{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:17:46Z","timestamp":1698369466541},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1995,7]]},"DOI":"10.1007\/bf01254566","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T13:09:40Z","timestamp":1111583380000},"page":"645-651","source":"Crossref","is-referenced-by-count":16,"title":["Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences"],"prefix":"10.1007","volume":"22","author":[{"given":"Christof","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Villena-Heinsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwin","family":"Trampert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Lung-Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Oberhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Martin","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1471-0528.1985.tb01095.x","volume":"92","author":"JO Davies","year":"1985","unstructured":"Davies JO, Davies ER, Howe K, et al. Radionuclide imaging of ovarian tumours with123I-labelled monoclonal antibody (NDOG2) directed against placental alkaline phosphatase.Br J Obstet Gynaecol 1985; 92: 277?286.","journal-title":"Br J Obstet Gynaecol"},{"key":"CR2","first-page":"1369","volume":"26","author":"N Pateisky","year":"1985","unstructured":"Pateisky N, Philipp K, Skodler WD, Czerwenka K, Hamilton G, Burchell J. Radioimmunodetection in patients with suspected ovarian cancer.J Nucl Med 1985; 26: 1369?1376.","journal-title":"J Nucl Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/1097-0142(19850301)55:5<984::AID-CNCR2820550511>3.0.CO;2-E","volume":"55","author":"AA Epenetos","year":"1985","unstructured":"Epenetos AA, Shepherd J, Britton KE, et al.123I radioiodinated antibody imaging of occult ovarian cancer.Cancer 1985; 55:984?987.","journal-title":"Cancer"},{"key":"CR4","first-page":"1807","volume":"28","author":"JF Chatal","year":"1987","unstructured":"Chatal JF, Fumoleau P, Saccavini JC, et al. Immunoscintigraphy of recurrences of gynecologic carcinomas.J Nucl Med 1987;28: 1807?1819.","journal-title":"J Nucl Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/172460088800300306","volume":"3","author":"RP Baum","year":"1988","unstructured":"Baum RP, Lorenz M, Hottenrott C, et al. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA125.Int J Biol Markers 1988; 3: 177?184.","journal-title":"Int J Biol Markers"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00006231-198805000-00003","volume":"9","author":"S Lastoria","year":"1988","unstructured":"Lastoria S, D'Amico P, Mansi L, et al. A prospective imaging study of131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report.Nucl Med Conunun 1988;9:347?356.","journal-title":"Nucl Med Conunun"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/172460089000500208","volume":"5","author":"M Granowska","year":"1990","unstructured":"Granowska M, Mather SJ, Jobling T, et al. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.Int J Biol Markers 1990; 5: 89?96.","journal-title":"Int J Biol Markers"},{"key":"CR8","first-page":"126","volume":"135","author":"MR Buist","year":"1991","unstructured":"Buist MR, Roos JC, Vermorken JB, Golding RP, Burger CW, Kenemans P. The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma.Ned Tijdschr Geneeskd 1991; 135: 126?130.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0277-5379(91)90174-C","volume":"27","author":"F Crippa","year":"1991","unstructured":"Crippa F, Buraggi GL, Di-Re E, et al. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.Eur J Cancer 1991; 27: 724?729.","journal-title":"Eur J Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0883-2897(91)90052-M","volume":"18","author":"S Del-Vecchio","year":"1991","unstructured":"Del-Vecchio S, Camera L, Petrillo A, et al. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.Int J Rad Appl Instrum [B] 1991; 18: 85?87.","journal-title":"Int J Rad Appl Instrum [B]"},{"key":"CR11","first-page":"999","volume":"104","author":"B Han","year":"1991","unstructured":"Han B, Liu CG, Fang YX, et al. Radioimmunolocalization of human malignant tumors with In-111 labeled monoclonal antibody.Chin Med J (Engl) 1991; 104: 999?1004.","journal-title":"Chin Med J (Engl)"},{"key":"CR12","first-page":"249","volume":"31","author":"L Trampert","year":"1992","unstructured":"Trampert L, Villena C, Benz P, Keweloh HC, Schmidt W, Oberhausen E. A clinical evaluation of MAb BW 835\/6 in breast and ovarian cancer.Nucl Med 1992; 31: 249?253.","journal-title":"Nucl Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00181760","volume":"20","author":"M Granowska","year":"1993","unstructured":"Granowska M, Britton KE, Mather SJ, et al. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.Eur J Nucl Med 1993; 20:483?4889.","journal-title":"Eur J Nucl Med"},{"key":"CR14","first-page":"297","volume":"4","author":"GD MacLean","year":"1991","unstructured":"MacLean GD, McEwan AL, Noujaim AA, et al. Two novel monoclonal antibodies have potential for gynecologic cancer imaging.Antibody Immunoconjugates Radiopharmaceuticals 1991;4:297?308.","journal-title":"Antibody Immunoconjugates Radiopharmaceuticals"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00006231-199201000-00003","volume":"13","author":"AJB McEwan","year":"1992","unstructured":"McEwan AJB, MacLean GD, Hooper HR, et al. MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with99Tcm and with111In.Nucl Med Commun 1992; 13: 11?19.","journal-title":"Nucl Med Commun"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00253598","volume":"15","author":"G Barzen","year":"1989","unstructured":"Barzen G, Mayr AC, Langer M, et al. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.Eur J Nucl Med 1989; 15: 42?48.","journal-title":"Eur J Nucl Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2008-1033338","volume":"153","author":"G Barzen","year":"1990","unstructured":"Barzen G, Cordes M, Langer M, Friedman W, Mayr AC, Felix R. Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma. Rofo Fortschr Geb Rontgenstr Nuklearmed 1990; 153: 85?91.","journal-title":"Rofo Fortschr Geb Rontgenstr Nuklearmed"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0883-2897(89)90183-9","volume":"16","author":"L Mansi","year":"1989","unstructured":"Mansi L, Panza N, Lastoria S, Pacilio G, Salvatore M. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using131-B72.3.Int J Rad Appl Instrum [B] 1989; 16: 127?135.","journal-title":"Int J Rad Appl Instrum [B]"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF02417452","volume":"245","author":"N Pateisky","year":"1989","unstructured":"Pateisky N, Gitsch E. Immunoscintigraphy and intraoperative tumor search in ovarian cancer.Arch Gynecol Obstet 1989; 245:606?609.","journal-title":"Arch Gynecol Obstet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/172460089000500401","volume":"5","author":"A Jimenez-Vicioso","year":"1990","unstructured":"Jimenez-Vicioso A, Torres M, Jimenez-Heffernan A, et al. Immunoscintigraphy with131I or111In labelled OC 125 F(ab?)2 fragments in patients with ovarian carcinoma.Int J Biol Markers 1990; 5: 159?165.","journal-title":"Int J Biol Markers"},{"key":"CR21","first-page":"937s","volume":"50","author":"P Lehtovirta","year":"1990","unstructured":"Lehtovirta P, Kairemo KJ, Liewendahl K, Seppala M. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab?)2 fragments of monoclonal antibody OC 125. Cancer Res 1990; 50: 937s-940s.","journal-title":"Cancer Res"},{"key":"CR22","first-page":"1802","volume":"31","author":"LF Massuger","year":"1990","unstructured":"Massuger LF, Kenemans P, Claessens RA, et al. Immunoscintigraphy of ovarian cancer with indium-111- labeled OV-TL 3 F(ab?)2 monoclonal antibody.J Nucl Med 1990; 31: 1802?1810.","journal-title":"J Nucl Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0028-2243(90)90035-Y","volume":"37","author":"V Papazefkos","year":"1990","unstructured":"Papazefkos V, Michalas S, Papantoniou V, et al. Comparative study of RIS with the131I-OC 125 F(ab?)2 Mab and CT scan prior to second look operation for ovarian cancer.Eur J Obstet Gynecol Reprod Biol 1990; 37: 271?277.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jso.2930510405","volume":"51","author":"DN Krag","year":"1992","unstructured":"Krag DN, Haseman MK, Ford P, et al. Gamma probe location of111indium-labeled B72.3: an extension of immunoscintigraphy.J Surg Oncol 1992; 51: 226?230.","journal-title":"J Surg Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006231-199212000-00006","volume":"13","author":"JG Tibben","year":"1992","unstructured":"Tibben JG, Massuger LF, Claessens RA, et al. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab? in patients suspected of ovarian cancer.Nucl Med Commun 1992; 13: 885?893.","journal-title":"Nucl Med Commun"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1200\/JCO.1986.4.5.730","volume":"4","author":"M Granowska","year":"1986","unstructured":"Granowska M, Britton KE, Shepard JH, et al. A prospective study of I-123 labeled monoclonal antibody imaging in ovarian cancer.J Clin Oncol 1986; 4: 730?736.","journal-title":"J Clin Oncol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0028-2243(88)80025-X","volume":"29","author":"P Kenemans","year":"1988","unstructured":"Kenemans P, Yedema CA, Hilgers JH, et al. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.Eur J Obstet Gynecol Reprod Biol 1988; 29: 207?218.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0883-2897(88)90014-1","volume":"15","author":"MR Zalutsky","year":"1988","unstructured":"Zalutsky MR, Knapp RC, Bast RC Jr. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.Int J Rad Appl Instrum [B] 1988; 15: 431?437.","journal-title":"Int J Rad Appl Instrum [B]"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1471-0528.1988.tb06532.x","volume":"95","author":"SH Kennedy","year":"1988","unstructured":"Kennedy SH, Soper ND, Mojiminiyi OA, Shepstone BJ, Barlow DH. Immunoscintigraphy of ovarian endometriosis. A preliminary study.Br J Obstet Gynoecol 1988, 95: 693?697.","journal-title":"Br J Obstet Gynoecol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000417790","volume":"24","author":"SH Kennedy","year":"1990","unstructured":"Kennedy SH, Mojiminiyi OA, Soper ND, Shepstone BJ, Barlow DH. Immunoscintigraphy of endometriosis.Front Radiat Ther Oncol 1990; 24: 228?239.","journal-title":"Front Radiat Ther Oncol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/030089168907500524","volume":"75","author":"R Veggian","year":"1989","unstructured":"Veggian R, Fasolato S, M\ufffdnard S, et al. Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues.Tumori 1989; 75: 510?513.","journal-title":"Tumori"},{"key":"CR32","first-page":"251","volume":"13","author":"JF Bouvier","year":"1988","unstructured":"Bouvier JF, Pernod J, Rivoire M, Maiassi N. Serum levels of tumor markers and presence of human antimouse antibodies: implications for diagnosis and treatment with radiolabeled monoclonal antibodies.Cancer Detect Prev 1988; 13: 251?262.","journal-title":"Cancer Detect Prev"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01560083","volume":"244","author":"J Brokelmann","year":"1989","unstructured":"Brokelmann J, Bockisch A, Vogel J, et al. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.Arch Gynecol Obstet 1989; 244: 193?206.","journal-title":"Arch Gynecol Obstet"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0028-2243(89)90124-X","volume":"32","author":"E Gitsch","year":"1989","unstructured":"Gitsch E, Pateisky N, Schatten C. Diagnostic and intraoperative immunoscintigraphy in ovarian cancer.Eur J Obstet Gynecol Reprod Biol 1989; 32: 33?37.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/0002-9378(89)90667-4","volume":"161","author":"MG Muto","year":"1989","unstructured":"Muto MG, Lepisto EM, Van-den Abbeele AD, Knapp RC, Kassis AI. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.Am J Obstet Gynecol 1989; 161: 1206?1212.","journal-title":"Am J Obstet Gynecol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01783164","volume":"242","author":"E Gitsch","year":"1987","unstructured":"Gitsch E, Pateisky N. Radioimmunoscintigraphy in ovarian cancer: theoretical principles and clinical experiences.Arch Gynecol Obstet 1987; 242: 365?370.","journal-title":"Arch Gynecol Obstet"},{"key":"CR37","first-page":"1428","volume":"29","author":"DJ Hnatowich","year":"1988","unstructured":"Hnatowich DJ, Chinol M, Siebecker DA, et al. Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody.J Nucl Med 1988; 29: 1428?1435.","journal-title":"J Nucl Med"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.2910410725","volume":"2","author":"HJ Haisma","year":"1988","unstructured":"Haisma HJ, Moseley KR, Battaile AI, Griffiths TC, Zurawski VR, Knapp RC. Biodistribution, pharmacokinetics and imaging of131I-labelled OC125 in ovarian cancer.Int J Cancer Suppl 1988; 2: 109?113.","journal-title":"Int J Cancer Suppl"},{"key":"CR39","first-page":"1910","volume":"29","author":"J Malamitsi","year":"1988","unstructured":"Malamitsi J, Skarlos D, Fotiou S, et al. Intracavitary use of two radiolabeled tumor- associated monoclonal antibodies.J Nucl Med 1988; 29: 1910?1915.","journal-title":"J Nucl Med"},{"key":"CR40","first-page":"607","volume":"76","author":"J Bell","year":"1990","unstructured":"Bell J, Mojzisik C, Hinkle G Jr, Derman H, Schlom J, Martin E. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.Obstet Gynecol 1990; 76: 607?611.","journal-title":"Obstet Gynecol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.2930480504","volume":"2","author":"JW Greiner","year":"1991","unstructured":"Greiner JW, Smalley RV, Borden EC, et al. Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.J Surg Oncol Suppl 1991; 2: 9?13.","journal-title":"J Surg Oncol Suppl"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01254566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01254566\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01254566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T06:54:10Z","timestamp":1556780050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01254566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["BF01254566"],"URL":"https:\/\/doi.org\/10.1007\/bf01254566","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}